These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 8368362

  • 1. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries.
    Ku DD, Zaleski JK, Liu S, Brock TA.
    Am J Physiol; 1993 Aug; 265(2 Pt 2):H586-92. PubMed ID: 8368362
    [Abstract] [Full Text] [Related]

  • 2. Effects of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidney.
    Klanke B, Simon M, Röckl W, Weich HA, Stolte H, Gröne HJ.
    Nephrol Dial Transplant; 1998 Apr; 13(4):875-85. PubMed ID: 9568844
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
    Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner JM.
    Circulation; 1998 Apr; 97(1):99-107. PubMed ID: 9443437
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor-mediated, endothelium-dependent relaxation in human internal mammary artery.
    Liu MH, Jin H, Floten HS, Ren Z, Yim AP, He GW.
    Ann Thorac Surg; 2002 Mar; 73(3):819-24. PubMed ID: 11899958
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
    Sioussat TM, Dvorak HF, Brock TA, Senger DR.
    Arch Biochem Biophys; 1993 Feb 15; 301(1):15-20. PubMed ID: 8442657
    [Abstract] [Full Text] [Related]

  • 10. Effects of VEGF on Ca(2+)-transient in cultured lymphatic endothelial cells and mechanical activity of isolated lymph vessels.
    Arai F, Mizuno R, Ohhashi T.
    Jpn J Physiol; 2000 Jun 15; 50(3):343-55. PubMed ID: 11016985
    [Abstract] [Full Text] [Related]

  • 11. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells.
    Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, Berse B, Elicker BM, Ledbetter S, Dvorak HF.
    J Invest Dermatol; 1995 Jul 15; 105(1):44-50. PubMed ID: 7615975
    [Abstract] [Full Text] [Related]

  • 12. Receptor mechanism of thrombin-induced endothelium-dependent and endothelium-independent coronary vascular effects in dogs.
    Ku DD, Zaleski JK.
    J Cardiovasc Pharmacol; 1993 Oct 15; 22(4):609-16. PubMed ID: 7505364
    [Abstract] [Full Text] [Related]

  • 13. Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity.
    Criscuolo GR, Lelkes PI, Rotrosen D, Oldfield EH.
    J Neurosurg; 1989 Dec 15; 71(6):884-91. PubMed ID: 2585081
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium.
    Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M.
    Am J Physiol; 1996 Jan 15; 270(1 Pt 2):H411-5. PubMed ID: 8769777
    [Abstract] [Full Text] [Related]

  • 15. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells.
    Brock TA, Dvorak HF, Senger DR.
    Am J Pathol; 1991 Jan 15; 138(1):213-21. PubMed ID: 1987767
    [Abstract] [Full Text] [Related]

  • 16. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation.
    Watanabe Y, Dvorak HF.
    Exp Cell Res; 1997 Jun 15; 233(2):340-9. PubMed ID: 9194496
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.
    Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo DW, Symes J, Isner JM.
    Am J Pathol; 1997 May 15; 150(5):1673-85. PubMed ID: 9137092
    [Abstract] [Full Text] [Related]

  • 18. VEGF induces NO-dependent hyperpermeability in coronary venules.
    Wu HM, Huang Q, Yuan Y, Granger HJ.
    Am J Physiol; 1996 Dec 15; 271(6 Pt 2):H2735-9. PubMed ID: 8997338
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms underlying endothelium-dependent, nitric oxide- and prostanoid-independent relaxation in monkey and dog coronary arteries.
    Fujioka H, Ayajiki K, Shinozaki K, Toda N, Okamura T.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov 15; 366(5):488-95. PubMed ID: 12382080
    [Abstract] [Full Text] [Related]

  • 20. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.
    Shen H, Clauss M, Ryan J, Schmidt AM, Tijburg P, Borden L, Connolly D, Stern D, Kao J.
    Blood; 1993 May 15; 81(10):2767-73. PubMed ID: 8490183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.